1 2 3 4 5 6 7 8 9 10 11 12

читать далее ... роль и динамическое наблюдение. Литература 1. Прилепская ВН. Пролонгированная контрацепция — новый подход к решению женских проблем. Гинекология. 200 5; 7 (4); 224-6. 2.AndristLC, HoytJ, Weinstein D, McGihbon C. The need to bleed: women's attitudes and beliefs about menstrual suppression. J Am Acad Nurse Pract 2004; 16(1):31-7. 3.ARHP/NPWH. Obstacles to using extended contraceplii v regimens. Clin Proc 2003: (April): 11 -2. 4. Assoc lalion a/ Reproductive Health I'l'o/c'ssionals. Choosing ii'/ien In menstruate: the role of extended conlruceplion. Kelrieved April 21, 2004 from http://arliphoru/healthcareprovidcrs/visitiimfacultvprograms/extended national surver, dm: 2002. 5. Back I~)J, Breckenridge AW, Crauford F et al. Interindividiial raniilioii and drug interactions with hormonal steroid contraceptires. Drugs 1981; 21: 46-61. 6.Back D/, GrimmerSFM, Orme MUB et al. Evaluation of committee on safety of medicines yellow card reports on oral contrace/ftive-iinig interactions with anticom 'ulsants and antibiotics. Вг J Clin Pharmcicol 1988: 25: 52"-i2. 7. Back l)f, Orine Ml.I:. Pliarmacokinetic drag interactions with ozal contraceptives. Clin Pharmacokinelic 1990; 18:472-84. 8. Birkhaiiser M. Braendle W, Breckwoldl M et al. 24th Workshop o/ Hie '/archer Gesprachskreis' May 201)0: recommendations on oral contraception. Fraiienarzt 2000:41: 1053-8. 9. Blanchard If. l.ife 4'ithoiil menstruation. The Obstetrician Gynecologist 2003; 5: 34-7. 10. Bloemeiikaml> KWM. Rosendaal FR, Bueller HR et al. Risk of l 'enons thrombosis и •ilh use of current low-dose oral i. onlracefilil vs is not explained by diagnostic sus/iicion and refen'al bias. Arch Intern Mod 1999: / W: 65-"0. 11. Bioemenkamp KWM, Rosendaal FR, Helmerhorst FM el al Higher risk of i 'enous thrombosis during early use of oral contraceptives in women with inherited clotting defects Arch Intern Med 2000; 160:49-52. 12. Bunion IA, Vessey MP, FlaveIR et al. Risk factors for benign breast disease Am { Epidemiol 1981; 1J3:203-14. 13. Contraceptive Method.Mix.Guidlines for policy andserrice delivery, Geneva: WHO. 1994. 14. Coiilin/io /;'.l/, de Sonza fC. CsapoAl. Reversible sterility induced by medrox-ylirogesterone injections. Fc'rlil Steril 1966: I "; 261 -6. 15. DArcy PI''. Drug interactions u'ith oral contraceptives. Drug Intell Clin Pbarm 1986; 20: 353-62. 16. Edelman A. Menstrual nirvana: amenorrhea through the use of continuous oral contraceptives Curr Womens Health Kc-p 2002: 2. 434-Я. 17. Eraser IS, fansen KPS. Why do inadvertent pregnancies occur in oral contraceptive users? Effectiveness of oral contraceptive regimens and interfering factors. Contraception 1983; 27: 531-51. 18. Fan-ou'A, Hull MGK, Norlhstone К. et al. Prolonged use of oral contraception he/ore a planned pregnancy is associated with a decreased risk of delayed conception. Hum Reprod 2002; 10: 2754-61. 19. Fotherhy К. Interactions with oral contraceptives. Am J CihstetGynecol 1990; 163:2153-9. 20. FriedmaiiAI. Thomas PP. Does lИсточник: Прилепская В.Н., Чернышова Е.С. Гинекология. 2005. Т.7. №5-6. С.270-275